这是一篇来自已证抗体库的有关人类 CCR4的综述,是根据28篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CCR4 抗体。
CCR4 同义词: CC-CKR-4; CD194; CKR4; CMKBR4; ChemR13; HGCN:14099; K5-5

BioLegend
小鼠 单克隆(L291H4)
  • 流式细胞仪; 人类
BioLegend CCR4抗体(BioLegend, 359420)被用于被用于流式细胞仪在人类样本上. Cell (2021) ncbi
小鼠 单克隆(L291H4)
  • 流式细胞仪; 人类; 图 s1
BioLegend CCR4抗体(BioLegend, L291H4)被用于被用于流式细胞仪在人类样本上 (图 s1). elife (2020) ncbi
小鼠 单克隆(L291H4)
  • 流式细胞仪; 人类; 图 4e-4f
BioLegend CCR4抗体(BioLegend, 359404)被用于被用于流式细胞仪在人类样本上 (图 4e-4f). elife (2020) ncbi
小鼠 单克隆(L291H4)
  • 流式细胞仪; 小鼠; 图 s2u
BioLegend CCR4抗体(BioLegend, L291H4)被用于被用于流式细胞仪在小鼠样本上 (图 s2u). Cell (2020) ncbi
小鼠 单克隆(L291H4)
  • 流式细胞仪; 人类; 1:100; 图 2b
BioLegend CCR4抗体(Biolegend, 359408)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 2b). elife (2020) ncbi
小鼠 单克隆(L291H4)
  • 流式细胞仪; 人类; 图 s20
BioLegend CCR4抗体(Biolegend, 359411)被用于被用于流式细胞仪在人类样本上 (图 s20). Science (2019) ncbi
小鼠 单克隆(L291H4)
  • 流式细胞仪; 人类; 图 s3
BioLegend CCR4抗体(BioLegend, L291H4)被用于被用于流式细胞仪在人类样本上 (图 s3). Eur J Immunol (2019) ncbi
小鼠 单克隆(L291H4)
  • 流式细胞仪; 人类; 图 s2f
BioLegend CCR4抗体(BioLegend, 359406)被用于被用于流式细胞仪在人类样本上 (图 s2f). Cell (2019) ncbi
小鼠 单克隆(L291H4)
  • 流式细胞仪; 人类; 图 s1
BioLegend CCR4抗体(BioLegend, L291H4)被用于被用于流式细胞仪在人类样本上 (图 s1). Oncoimmunology (2017) ncbi
小鼠 单克隆(L291H4)
  • 流式细胞仪; 人类; 图 2f
BioLegend CCR4抗体(BioLegend, L291H4)被用于被用于流式细胞仪在人类样本上 (图 2f). Am J Transplant (2017) ncbi
小鼠 单克隆(L291H4)
  • 流式细胞仪; 人类; 图 3a
BioLegend CCR4抗体(Biolegend, L291H4)被用于被用于流式细胞仪在人类样本上 (图 3a). PLoS ONE (2016) ncbi
小鼠 单克隆(L291H4)
  • 流式细胞仪; 人类; 图 4a
BioLegend CCR4抗体(biolegend, L291H4)被用于被用于流式细胞仪在人类样本上 (图 4a). J Immunol (2016) ncbi
小鼠 单克隆(L291H4)
  • 流式细胞仪; 人类
BioLegend CCR4抗体(Biolegend, L291H4)被用于被用于流式细胞仪在人类样本上. Mol Oncol (2015) ncbi
艾博抗(上海)贸易有限公司
domestic goat 多克隆
  • 免疫组化-石蜡切片; 人类; 1:300; 图 s1a
  • 流式细胞仪; 人类; 图 s2
艾博抗(上海)贸易有限公司 CCR4抗体(Abcam, ab1669)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:300 (图 s1a) 和 被用于流式细胞仪在人类样本上 (图 s2). J Clin Invest (2017) ncbi
碧迪BD
小鼠 单克隆(1G1)
  • 流式细胞仪; 人类; 图 2c
碧迪BD CCR4抗体(BD Biosciences, 561110)被用于被用于流式细胞仪在人类样本上 (图 2c). Blood Cancer J (2022) ncbi
小鼠 单克隆(1G1)
  • 流式细胞仪; 人类; 图 1
碧迪BD CCR4抗体(BD, 1G1)被用于被用于流式细胞仪在人类样本上 (图 1). Arthritis Res Ther (2021) ncbi
小鼠 单克隆(1G1)
  • 流式细胞仪; 人类; 图 7b
碧迪BD CCR4抗体(BD Pharmingen, 1G1)被用于被用于流式细胞仪在人类样本上 (图 7b). elife (2017) ncbi
小鼠 单克隆(1G1)
  • 流式细胞仪; 人类; 图 1
碧迪BD CCR4抗体(BD Biosciences, 551120)被用于被用于流式细胞仪在人类样本上 (图 1). J Cell Physiol (2017) ncbi
小鼠 单克隆(1G1)
  • 流式细胞仪; 人类; 图 4
碧迪BD CCR4抗体(BD Biosciences, 1G1)被用于被用于流式细胞仪在人类样本上 (图 4). J Allergy Clin Immunol (2018) ncbi
小鼠 单克隆(1G1)
  • 流式细胞仪; 人类
碧迪BD CCR4抗体(BD Biosciences, 1G1)被用于被用于流式细胞仪在人类样本上. Int J Cancer (2017) ncbi
小鼠 单克隆(1G1)
  • 流式细胞仪; 人类; 图 5d
碧迪BD CCR4抗体(BD Biosciences, 1G1)被用于被用于流式细胞仪在人类样本上 (图 5d). J Immunol (2016) ncbi
小鼠 单克隆(1G1)
  • 流式细胞仪; 人类; 图 3
碧迪BD CCR4抗体(Pharmingen, 1G1)被用于被用于流式细胞仪在人类样本上 (图 3). Cell Mol Immunol (2017) ncbi
小鼠 单克隆(1G1)
  • 流式细胞仪; 人类; 图 3a
碧迪BD CCR4抗体(BD Biosciences, 1G1)被用于被用于流式细胞仪在人类样本上 (图 3a). PLoS ONE (2015) ncbi
小鼠 单克隆(1G1)
  • 流式细胞仪; 人类; 图 1
碧迪BD CCR4抗体(BD Biosciences, 1G1)被用于被用于流式细胞仪在人类样本上 (图 1). Retrovirology (2015) ncbi
小鼠 单克隆(1G1)
  • 流式细胞仪; 小鼠; 1:1000
碧迪BD CCR4抗体(BD Bioscience, 1G1)被用于被用于流式细胞仪在小鼠样本上浓度为1:1000. J Endod (2016) ncbi
小鼠 单克隆(1G1)
  • 流式细胞仪; 人类
碧迪BD CCR4抗体(BD Biosciences, 1G1)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(1G1)
  • 流式细胞仪; 人类
碧迪BD CCR4抗体(BD Biosciences, 1G1)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(1G1)
  • 流式细胞仪; 人类; 图 1
碧迪BD CCR4抗体(BD Bioscience, 1G1)被用于被用于流式细胞仪在人类样本上 (图 1). J Immunol (2014) ncbi
文章列表
  1. Geng X, Wang C, Gao X, Chowdhury P, Weiss J, Villegas J, et al. GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms. Blood Cancer J. 2022;12:149 pubmed 出版商
  2. Rosshirt N, Trauth R, Platzer H, Tripel E, Nees T, Lorenz H, et al. Proinflammatory T cell polarization is already present in patients with early knee osteoarthritis. Arthritis Res Ther. 2021;23:37 pubmed 出版商
  3. Rodda L, Netland J, Shehata L, Pruner K, Morawski P, Thouvenel C, et al. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19. Cell. 2021;184:169-183.e17 pubmed 出版商
  4. Kasatskaya S, Ladell K, Egorov E, Miners K, Davydov A, Metsger M, et al. Functionally specialized human CD4+ T-cell subsets express physicochemically distinct TCRs. elife. 2020;9: pubmed 出版商
  5. Bhattacharya P, Ellegård R, Khalid M, Svanberg C, Govender M, Keita A, et al. Complement opsonization of HIV affects primary infection of human colorectal mucosa and subsequent activation of T cells. elife. 2020;9: pubmed 出版商
  6. Pasciuto E, Burton O, Roca C, Lagou V, Rajan W, Theys T, et al. Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell. 2020;182:625-640.e24 pubmed 出版商
  7. Bennstein S, Weinhold S, Manser A, Scherenschlich N, Noll A, Raba K, et al. Umbilical cord blood-derived ILC1-like cells constitute a novel precursor for mature KIR+NKG2A- NK cells. elife. 2020;9: pubmed 出版商
  8. Uhlen M, Karlsson M, Zhong W, Tebani A, Pou C, Mikes J, et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science. 2019;366: pubmed 出版商
  9. Remmerswaal E, Hombrink P, Nota B, Pircher H, ten Berge I, van Lier R, et al. Expression of IL-7Rα and KLRG1 defines functionally distinct CD8+ T-cell populations in humans. Eur J Immunol. 2019;49:694-708 pubmed 出版商
  10. Bacher P, Hohnstein T, Beerbaum E, Röcker M, Blango M, Kaufmann S, et al. Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans. Cell. 2019;: pubmed 出版商
  11. Lepore M, Kalinichenko A, Calogero S, Kumar P, Paleja B, Schmaler M, et al. Functionally diverse human T cells recognize non-microbial antigens presented by MR1. elife. 2017;6: pubmed 出版商
  12. Tong A, Hashem H, Eid S, Allen F, Kingsley D, Huang A. Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma. Oncoimmunology. 2017;6:e1303586 pubmed 出版商
  13. Buskermolen J, Roffel S, Gibbs S. Stimulation of oral fibroblast chemokine receptors identifies CCR3 and CCR4 as potential wound healing targets. J Cell Physiol. 2017;232:2996-3005 pubmed 出版商
  14. Sullivan A, Wang E, Farrell J, Whitaker P, Faulkner L, Peckham D, et al. ?-Lactam hypersensitivity involves expansion of circulating and skin-resident TH22 cells. J Allergy Clin Immunol. 2018;141:235-249.e8 pubmed 出版商
  15. Berlato C, Khan M, Schioppa T, Thompson R, Maniati E, Montfort A, et al. A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer. J Clin Invest. 2017;127:801-813 pubmed 出版商
  16. Boardman D, Philippeos C, Fruhwirth G, Ibrahim M, Hannen R, Cooper D, et al. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection. Am J Transplant. 2017;17:931-943 pubmed 出版商
  17. Nagase H, Takeoka T, Urakawa S, Morimoto Okazawa A, Kawashima A, Iwahori K, et al. ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori. Int J Cancer. 2017;140:686-695 pubmed 出版商
  18. Gadd V, Patel P, Jose S, Horsfall L, Powell E, Irvine K. Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation. PLoS ONE. 2016;11:e0157771 pubmed 出版商
  19. Loyon R, Picard E, Mauvais O, Queiroz L, Mougey V, Pallandre J, et al. IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner. J Immunol. 2016;197:85-96 pubmed 出版商
  20. Moura J, Rodrigues J, Goncalves M, Amaral C, Lima M, Carvalho E. Impaired T-cell differentiation in diabetic foot ulceration. Cell Mol Immunol. 2017;14:758-769 pubmed 出版商
  21. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed 出版商
  22. Paris R, Petrovas C, Ferrando Martinez S, Moysi E, Boswell K, Archer E, et al. Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression. PLoS ONE. 2015;10:e0144767 pubmed 出版商
  23. Cleret Buhot A, Zhang Y, Planas D, Goulet J, Monteiro P, Gosselin A, et al. Identification of novel HIV-1 dependency factors in primary CCR4(+)CCR6(+)Th17 cells via a genome-wide transcriptional approach. Retrovirology. 2015;12:102 pubmed 出版商
  24. Francisconi C, Vieira A, Biguetti C, Glowacki A, Trombone A, Letra A, et al. Characterization of the Protective Role of Regulatory T Cells in Experimental Periapical Lesion Development and Their Chemoattraction Manipulation as a Therapeutic Tool. J Endod. 2016;42:120-6 pubmed 出版商
  25. Wang Z, Wei M, Zhang H, Chen H, Germana S, Huang C, et al. Diphtheria-toxin based anti-human CCR4 immunotoxin for targeting human CCR4(+) cells in vivo. Mol Oncol. 2015;9:1458-70 pubmed 出版商
  26. Kamburova E, Koenen H, van den Hoogen M, Baas M, Joosten I, Hilbrands L. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy. PLoS ONE. 2014;9:e112658 pubmed 出版商
  27. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed 出版商
  28. Arlehamn C, Seumois G, Gerasimova A, Huang C, Fu Z, Yue X, et al. Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features. J Immunol. 2014;193:2931-40 pubmed 出版商